Sie suchten nach: Vitamin K1 (Phytomenadion, Phyllochinon)

26  results were found

FectoCHO Expression System - Flyer

FectoCHO Expression System - Flyer 0 1 2 3 4 5 Freestyle™ Max F17 FectoPRO® F17 FectoPRO® FectoCHO™ CD P ro te in Y ie ld F o ld In cr ea se Reach the highest yields with a complementary medium and transfection reagent! Product Reference Expressio...

FectoCHO Expression System - Flyer

FectoCHO Expression System - Flyer 0 1 2 3 4 5 Freestyle™ Max F17 FectoPRO® F17 FectoPRO® FectoCHO™ CD P ro te in Y ie ld F o ld In cr ea se Reach the highest yields with a complementary medium and transfection reagent! Product Reference Expressio...

FectoCHO Expression System - Flyer

FectoCHO Expression System - Flyer 0 1 2 3 4 5 Freestyle™ Max F17 FectoPRO® F17 FectoPRO® FectoCHO™ CD P ro te in Y ie ld F o ld In cr ea se Reach the highest yields with a complementary medium and transfection reagent! Product Reference Expressio...

Présentation PowerPoint

Présentation PowerPoint Advanced CHO Cell Expression System for Increased Transient Protein Production 0 20 40 60 80 100 0 2 4 6 8 10 12 0 24 48 72 96 120 V ia b ili ty ( % ) V ia b le C el l D en si ty ( x1 0 6 ce lls /m L) Time (h) Viable Cell D...

Présentation PowerPoint

Présentation PowerPoint Advanced CHO Cell Expression System for Increased Transient Protein Production 0 20 40 60 80 100 0 2 4 6 8 10 12 0 24 48 72 96 120 V ia b ili ty ( % ) V ia b le C el l D en si ty ( x1 0 6 ce lls /m L) Time (h) Viable Cell D...

Présentation PowerPoint

Présentation PowerPoint Advanced CHO Cell Expression System for Increased Transient Protein Production 0 20 40 60 80 100 0 2 4 6 8 10 12 0 24 48 72 96 120 V ia b ili ty ( % ) V ia b le C el l D en si ty ( x1 0 6 ce lls /m L) Time (h) Viable Cell D...

~~4 step method RR~~

The 4-Step Method 1. Identify the Hazards Application Hazard Typical Protection Painting Spraying Varnishing Coating Solvent-Based Paint** A2P3 R Anti-Fouling Paint Spraying / Grinding A2P3 R Water Soluble Paint A1P2 R Solvents Resins Synthetic Re...

General Description of an Application

General Description of an Application Application Date: 21.10.2013 Page 1 of 5 Quantitative analysis of ascorbic acid with Iodine titrant Application Date: 21.10.2013 Page 2 of 5 Use This method is used to determine the content of ascorbic acid (V...

General Description of an Application

General Description of an Application Application Date: 21.10.2013 Page 1 of 5 Quantitative analysis of ascorbic acid with Iodine titrant Application Date: 21.10.2013 Page 2 of 5 Use This method is used to determine the content of ascorbic acid (V...

General Description of an Application

General Description of an Application Application Date: 21.10.2013 Page 1 of 5 Quantitative analysis of ascorbic acid with Iodine titrant Application Date: 21.10.2013 Page 2 of 5 Use This method is used to determine the content of ascorbic acid (V...

~~R3971_AcroSep~~

R3971_AcroSep Various filter choices – Specialized membranes and media accomodates most applications to guarantee success. Optimized outlet tips – Minimizes sample leak- age during incubation steps and reduces the presence of hanging drops followi...

General Description of an Application

General Description of an Application Application Date: 23.01.2014 Page 1 of 8 Quantitative analysis of ascorbic acid with specific titrant DCPIP Application Date: 23.01.2014 Page 2 of 8 Use This method is used to determine the content of ascorbic...

General Description of an Application

General Description of an Application Application Date: 23.01.2014 Page 1 of 8 Quantitative analysis of ascorbic acid with specific titrant DCPIP Application Date: 23.01.2014 Page 2 of 8 Use This method is used to determine the content of ascorbic...

General Description of an Application

General Description of an Application Application Date: 23.01.2014 Page 1 of 8 Quantitative analysis of ascorbic acid with specific titrant DCPIP Application Date: 23.01.2014 Page 2 of 8 Use This method is used to determine the content of ascorbic...

29188433AA Production of recombinant monoclonal an

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

~~29271856AA maximize performance with sfm selection~~

Maximize performance with HyClone™ media and supplements gelifesciences.com 3 of 4 Maximize performance with HyClone media and supplements serum Maximize performance with HyClone media and supplements serum 3 of 4 Boost performance. Strengthen res...
1 - 16 of 26